Meet the team


Norm Farb Thumbnail

Norman Farb, PhD

Norman Farb is an assistant professor in the Department of Psychology and head of the Regulatory and Affective Dynamics Laboratory (RADLab) at the University of Toronto Mississauga. He has published numerous papers, chapters and reviews, including important neuroscientific research on meditation.

Medical Director 

Adam Blackman Thumbnail

Adam Blackman

Adam Blackman is a Toronto-based psychiatrist and healthcare entrepreneur focused on the research and development of potential novel therapeutics that promote mental health and wellness.  He is an adjunct Assistant Professor at the University of Toronto in the Department of Psychiatry, the founder of MedSleep and the CEO of Mavencare.

Research Director 

Thomas Anderson Thumbnail

Thomas Anderson

Thomas Anderson is a Cognitive Neuroscience PhD student at the University of Toronto (Toronto, Canada). Thomas is a strong proponent of open science and the open sharing of scientific findings. He has shared our research findings and presentations on ResearchGate and keeps an active account on Reddit to communicate publicly about this research.

Associate Director 

Rotem Petranker Thumbnail

Rotem Petranker

Rotem Petranker is a clinical psychology PhD student at York University (Toronto, Canada). His main research interests are sustained attention, emotional regulation and creativity, all of which are ostensibly affected by microdosing psychedelics.

 Research Associate - Head Pharmacist

Emily Kulpa Thumbnail

Emily Kulpa, PharmD

Emily Kulpa is a licensed clinical pharmacist with a background in medication therapy management focused on optimizing therapeutic outcomes. She is the Director of Medical Health Screening at Synthesis, a legal, medically supervised, psilocybin retreat center for professionals to experience personal growth, emotional breakthroughs, and spiritual development. Her current work involves developing and implementing protocols for the safe screening of retreat participants. Her current interests include use of psychedelic therapy to promote healing and personal growth, microdosing, and wellness.

Board of Directors

Our international board of advisers provide insights and oversight on all the various projects that pass through the Psychedelic Studies Research Program. Please note that list below is incomplete. Additional member information will be added as it becomes available.

Paul Seli Thumbnail

Paul Seli, Assistant Professor, Department of Psychology and Neuroscience, Duke University, USA

Paul Seli is an assistant professor in the Department of Psychology and Neuroscience at Duke University. His Mind at Large Lab is interested in identifying methods that optimize human cognitive processing. For example, his group is conducting research examining the possibility that the ubiquitous experience of mind wandering can, at times, serve beneficial functions (e.g., that it can facilitate creativity, the generation of “ah-ha” moments, and aid in problem-solving). Seli is also interested in the possibility that we might be able to leverage hypnagogic states to promote creativity, well-being, and, more generally, to allow people to increase productivity/functioning in their daily lives. More recently, Seli has become fascinated by the prospect that psychedelics might also be used to promote human cognitive processing.

Nathaniel Barr Thumbnail

Nathaniel Barr Professor, Creativity and Creative Thinking, Sheridan College, Canada

Nathaniel Barr is a professor of creativity and creative thinking at Sheridan College, specializing in cognitive psychology. Prior to joining Sheridan, he earned his BA, MA, and PhD, and held a postdoctoral fellowship in the Psychology Department at the University of Waterloo. He has published on a wide array of topics in psychology, including the psychology of creativity, human reason in the Anthropocene, religious and moral belief, mind wandering, how thinking is offloaded to technology, and how best to align artificial and human intelligence in the workforce. Barr is deeply interested in the way psychedelics interact with how humans think, believe, and behave, and the potential they might hold for enhancing cognition, creativity, and well-being in the context of the challenges of the Anthropocene.

​Nadav Shalit Thumbnail

Nadav Shalit Resident psychiatrist, Department of Psychiatry, Tel Aviv University, Israel

Nadav Shalit is a psychiatrist at the Addiction and Dual Diagnosis Clinic at The Israeli Center on Addictions. Prior to his current position, he earned an MD cum laude at the Goldman School of Medicine, Ben-Gurion University, Israel, completed a psychiatry residency at the Geha Mental Health Center and worked as a psychiatrist at the Lev-Hasharon Dual Diagnosis Clinic. He has published papers on the psychiatric comorbidity of substance use, focusing on cannabinoids and hallucinogens. Shalit is currently interested in the way psychedelics interact with the cognitive processes at the basis of addiction and chronic pain disorders, and in the potential of psychedelic-assisted psychotherapy in their treatment.